BROWNSTEIN HYATT FARBER SCHRECK, LLP

Lobbying for ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS · Pharmaceutical company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $80,000.00 income · posted Apr 15, 2026

Lobbying activity 2

Pharmacy

issues related to pharmaceutical manufacturing Tax and trade policy affecting the pharmaceutical industry

Trade (domestic/foreign)

Companys expansion of its domestic footprint.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.